Skip to main content
Fig. 7 | Cancer Cell International

Fig. 7

From: Bioinformatics prediction and experimental verification identify MAD2L1 and CCNB2 as diagnostic biomarkers of rhabdomyosarcoma

Fig. 7

Downregulation of MAD2L1 and CCNB2. a IF assessment of RH30 and RD cells transfected with si-MAD2L1 and si-CCNB2. Cells were stained with 4ʹ,6-diamidino-2-phenylindole (blue) and the antibody against MAD2L1 (green), exposed to the corresponding secondary antibody, and analysed with double IF assay. b Western blot shows the expression of siMAD2L1. c and d IF and Western blot shows the expression of siCCNB2

Back to article page